Homology Models of the Catalytic Sites of Phosphodiesterase 5A and 10A and Molecular Docking of Selective Apoptotic Antineoplastic Drugs (SAANDS)

International Journal of Quantum Chemistry

Volumn 96, Issue 4, 2004, Pages 402-410

  Salter, E A ^a   Wierzbicki, A ^b   Sperl, G ^c   Thompson, W J ^d  

^a University of South Alabama ^*  (United States)

^b UNIVERSITY OF SOUTH ALABAMA   (United States)

^c Cell Pathways Inc   (United States)

^d UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

Author keywords

CHARMm force field; Enzyme inhibition; Homology modeling; Phosphodiesterases; SAANDs

Indexed keywords

CATALYST ACTIVITY; CELLS; CRYSTAL STRUCTURE; DRUG PRODUCTS; X RAY ANALYSIS;

HOMOLOGY MODELING; PHOSPHODIESTERASES; SELECTIVE APOPTOTIC ANTINEOPLASTIC DRUGS (SAAND);

ENZYME INHIBITION;

EID: 0742322284     PISSN: 00207608     EISSN: None     Source Type: Journal    
DOI: 10.1002/qua.10733     Document Type: Conference Paper

References (24)

1. Corbin, J. D.; Francis, S. H. J Biol Chem 1999, 274, 13729.
2. Schmidt, D.; Dent, G.; Rabe, K. F. Clin Exp Allergy 1999, 29, 99.
3. Cortijo, J.; Bou, J.; Beleta, J.; Cardelus, I.; Llenas, J.; Morcillo, E. ; Gristwood, R. W. Br J Pharmacol 1993, 108, 562.
4. Rabe, K. F.; Tenor, H.; Dent, G.; Schudt, C.; Liebig, S.; Magnussen, H. Am J Physiol 1993, 264, L458.
5. Hidaka, H.; Endo, T. Protein Phosphoryl 1984, 16, 245.
6. Thompson, W. J.; Piazza, G. A.; Li, H.; Liu, L.; Fetter, J.; Zhu, B.; Sperl, G.; Ahnen, D.; Pamukcu, R. Cancer Res 2000, 60, 3338.
7. Xu, R. X.; Hassell, A. M.; Vanderwall, D.; Lambert, M. H.; Holmes, W. D. ; Luther, M. A.; Rocque, W. J.; Milburn, M. V.; Zhao, Y.; Ke, H.; Nolte, R. T. Science 2000, 288, 1822.
8. Van der Mey, M.; Hatzelmann, A.; Van der Laan, I. J.; Sterk, G. J.; Thibaut, U.; Timmerman, T. J Med Chem 2001, 44, 2511.
9. Dym, O.; Xenarios, I.; Ke, H.; Colicelli, J. Mol Pharmacol 2002, 61, 20.
10. Zhang, W.; Ke, H.; Tretiakova, A. P.; Jameson, B.; Coleman, R. W. Protein Sci 2001, 10, 1041.
11. Zhang, W.; Ke, H.; Coleman, R. W. Mol Pharmacol 2002, 62, 514.
12. Fujishige, K.; Kotera, J.; Michibata, H.; Yuasa, K.; Takebayashi, S.; Okumura, K.; Omori, K. J Biol Chem 1999, 274, 18438.
13. Guex, N.; Peitsch, M. C. Electrophoresis 1997, 18, 2714.
14. Peitsch, M. C. Biochem Soc Trans 1996, 24, 274.
15. Peitsch, M. C. Biotechnology 1995, 13, 658.
16. Quanta 98; Accelrys Inc., San Diego, CA, 1998.
17. CHARMm; Accelrys Inc., San Diego, CA, 1998.
18. C.C.J. Roothaan, Rev. Mod. Phys. 23 (1951) 69.
19. A. Frisch, M.J. Frisch, in: Gaussian 98 User's Reference, Gaussian, Inc. Pittsburgh, PA, 1998, pp. 25-27 and references therein.
20. Frisch, M. J.; Trucks, G. W.; Schlegel, H. B.; Scuseria, M. A.; Robb, M. A.; Cheeseman, J. R.; Zakrzewski, V. G.; Montgomery, J. A. Jr.; Stratman, R. E. ; Burant, J. C.; Daprich, S.; Millam, J. M.; Daniels, A. D.; Kudin, K. N.; Strain, M. C.; Farkas, O.; Tomasi, J.; Barone, V.; Cossi, M.; Cammi, R.; Mennucci, B.; Pomelli, C.; Adamo, C.; Clifford, S.; Ochterski, J.; Petersson, G. A.; Ayala, P. Y.; Ciu, Q.; Morokuma, K.; Salvador, P.; Dannenberg, J. J.; Malick, D. K.; Rabuck, A. D.; Raghavachari, K.; Foresman, J. B.; Cioslowski, J. ; Oritz, J. V.; Baboul, A. G.; Stefanov, B. B.; Liu, G.; Liashenko, A.; Piskorz, P.; Komaromi, I.; Gomperts, R.; Martin, R. L.; Fox, D. J.; Keith, T. A.; Al-Laham, M. A.; Peng, C. Y.; Nanayakkara, A.; Gonzales, C. A.; Head-Gordon, M. ; Replogle, E. S.; Pople, J. A. Gaussian 98, revision A.11; Gaussian, Inc.: Pittsburgh, PA, 1995.
21. Spartan, version 5.1.1; Wavefunction, Inc.: Irvine, CA, 1993.
22. Breneman, C. M.; Wiberg, K. B. J Comput Chem 1990, 11, 361.
23. Salter, E. A.; Wierzbicki, A.; Sperl, G.; Thompson, W. J. J Mol Struct Theochem 2001, 549, 111.
24. Piazza, G. A.; Thompson, W. J.; Pamukcu, R.; Alila, H. W.; Whitehead, C. M.; Liu, L.; Fetter, J. R.; Gresh, W. E.; Klein-Szanto, A. J.; Farnell, D. R.; Eto, I.; Grubbs, C. J. Cancer Res 2001, 61, 3961.